Loading ......
The Leptospira genus produces pathogenic spirochetes which result in the global zoonotic disease known as leptospirosis. Leptospirosis bacteria survive in warm and humid conditions allowing them to spread across numerous areas. Among all hosts, dogs serve as the primary carriers of leptospirosis - they possess a high vulnerability to infection. Dogs can become infected through multiple sources such as contaminated water and soil in addition to interactions with sick animals. Infected dogs become bacterial carriers who spread the infection through urine thereby endangering both humans and other animals.

| Step | Infection Pathway | Description |
| 1. Environmental Exposure | Contact with contaminated water or soil | Dogs are exposed when walking, swimming, or drinking from areas tainted by urine from infected animals. |
| 2. Ingestion or Contact | Bacteria enter via mucous membranes or skin | Entry occurs through mouth, nose, eyes, or broken skin when contacting contaminated sources. |
| 3. Direct Transmission | Contact with bodily fluids of infected animals | Infection spreads through urine, blood, or tissues of infected wildlife or other dogs. |
| 4. High-Risk Activities | Increased exposure during outdoor activities | Dogs involved in hunting, farming, or hiking are more frequently exposed to infection sources. |
Leptospirosis in dogs shows varying clinical signs which range from mild temporary symptoms to severe life-threatening. The clinical appearance of leptospirosis in dogs ranges from moderate transitory symptoms to catastrophic life-threatening diseases.

The disease usually goes through a few phases.
In some cases, dogs may experience a subclinical infection, where they show no outward symptoms but still carry and shed the bacteria. This makes early detection and diagnosis challenging for dog owners and veterinarians alike. If your dog exhibits any of these symptoms, especially after potential exposure to contaminated environments, it is crucial to seek veterinary care promptly.
1. Antibiotic Therapy
Immediate treatment leads to improved treatment outcomes
2. Supportive Care
The supportive care treatments help manage the symptoms and stop the development of organ damage.
3. Treatment Duration & Follow-Up

| Strategy | Details & Recommendations |
| 1. Vaccination | - Most effective preventive measure. - Use commercial vaccines to reduce risk and severity. - Not all strains covered, but significant protection offered. - Consult your vet for a suitable schedule based on your dog's lifestyle and risk. |
| 2. Avoid Contaminated Water | - Prevent your dog from drinking or swimming in stagnant or outdoor water sources. - Especially important in areas with known cases. |
| 3. Rodent Control | - Rodents are major carriers of Leptospira. - Keep your home and yard free of rodent activity. |
| 4. Environmental Hygiene | - Remove standing water from your property. - Regularly clean and disinfect your dog's bedding, bowls, and living areas. |
| 5. Risk-Based Consultation | - If you live in a high-risk region, discuss additional preventive strategies with your veterinarian. |
In conclusion, Leptospirosis poses a significant threat to canine health and can cause serious issues if not addressed effectively. Through knowledge about infection mechanisms combined with symptom detection and prevention strategies dog owners can effectively shield their pets from disease spread. Your pets need regular veterinary exams and updated information about local leptospirosis cases for their overall health protection.
References
| Target | Cat. No. | Product Name | Size | Species | Application | Detection Sample | |
| Leptospira | DEIA2332 | Leptospira Hardjo Antibody ELISA Kit | 96T | Bovine | Qualitative | Bovine serum | Inquiry |
| Leptospira | DEIA2332BG | Leptospira Hardjo IgG ELISA Kit | 96T | Bovine | Qualitative | Bovine milk and serum | Inquiry |
| L. biflexa | DEIA05738 | Rat Leptospira IgG ELISA Kit | 96T | Quantitative | Serum, plasma, biological fluids | Inquiry | |
| L. biflexa | DEIA05739M | Leptospira IgM ELISA Kit | 96T | Human | Quantitative | Serum, plasma | Inquiry |
| L. biflexa | DEIA05739 | Leptospira IgG ELISA Kit | 96T | Human | Quantitative and qualitative | serum or plasma | Inquiry |
| Target | Cat. No. | Product Name | Expression System | Tag/Conjugate | Application | |
| L. interrogans | DAG-WT5744 | Recombinant Leptospira interrogans LipL21 antigen [His] | N/A | Unconjugated | BL | Inquiry |
| L. interrogans | DAG-WT5745 | Recombinant Leptospira interrogans chimeric antigen [His] | Mammalian Cells | Fc | SDS-PAGE | Inquiry |
| L. interrogans | DAG-WT5746 | Recombinant Leptospira interrogans chimeric antigen [His] | WB | Inquiry | ||
| L. interrogans | DAG-WT5747 | Recombinant Leptospira interrogans chimeric antigen 2 [His] | WB | Inquiry | ||
| L. interrogans | DAG-WT5748 | Recombinant Leptospira interrogans chimeric antigen 3 [His] | WB | Inquiry | ||
| L. interrogans | DAG-WT5749 | Recombinant Leptospira antigen [His] | WB | Inquiry | ||
| L. interrogans | DAGA-3029 | Recombinant Leptospira interrogans lipl32 antigen [His] | WB | Inquiry | ||
| L. interrogans | DAG2697 | Recombinant Leptospira interrogans LipL32 antigen [His] | WB | Inquiry | ||
| L. biflexa | DAG4700 | Native L. biflexa Antigen | N/A | Unconjugated | BL, WB | Inquiry |
Loading ......